Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Beaume

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cell Reports Methods|April 27, 2022
Interrogating RNA and protein spatial subcellular distribution in smFISH data with DypFISHAnca F Savulescu, Robyn Brackin, Emmanuel Bouilhol, et al.
Gigascience|December 31, 2019
Corrigendum to: Rice Galaxy: an open resource for plant scienceVenice Juanillas, Alexis Dereeper, Nicolas Beaume, et al.
Gigascience|May 21, 2019
Rice Galaxy: an open resource for plant scienceVenice Juanillas, Alexis Dereeper, Nicolas Beaume, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2024
Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence featuresMichal Juraska, Hongjun Bai, Allan C deCamp, et al.
Plos Pathogens|June 29, 2023
Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trialsNonhlanhla N Mkhize, Anna E J Yssel, Haajira Kaldine, et al.
Nature Communications|April 3, 2026
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trialsCarolyn Williamson, Chivonne Moodley, Craig A Magaret, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trialsCarolyn Williamson, Chivonne Moodley, Craig A Magaret, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention TrialsCarolyn Williamson, Lyle Curry, Nonhlanhla N Mkhize, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cell Reports Methods|April 27, 2022
Interrogating RNA and protein spatial subcellular distribution in smFISH data with DypFISHAnca F Savulescu, Robyn Brackin, Emmanuel Bouilhol, et al.
Gigascience|December 31, 2019
Corrigendum to: Rice Galaxy: an open resource for plant scienceVenice Juanillas, Alexis Dereeper, Nicolas Beaume, et al.
Gigascience|May 21, 2019
Rice Galaxy: an open resource for plant scienceVenice Juanillas, Alexis Dereeper, Nicolas Beaume, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2024
Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence featuresMichal Juraska, Hongjun Bai, Allan C deCamp, et al.
Plos Pathogens|June 29, 2023
Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trialsNonhlanhla N Mkhize, Anna E J Yssel, Haajira Kaldine, et al.
Nature Communications|April 3, 2026
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trialsCarolyn Williamson, Chivonne Moodley, Craig A Magaret, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trialsCarolyn Williamson, Chivonne Moodley, Craig A Magaret, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention TrialsCarolyn Williamson, Lyle Curry, Nonhlanhla N Mkhize, et al.
Pageof 2